SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors deramiocel FDA decision for Duchenne muscular dystrophy, with a Nov. 22 target action date, dominates discussion; traders are weighing the amended upper-limb data and recent launch-related job postings as possible positive signs against the risk of another rejection. The FDAs rare-disease focus and INOVIOs approval are also cited as encouraging read-throughs, but approval expectations remain speculative and sentiment is divided.

OFFICIAL TRUMP (TRUMP) is a cryptocurrency and operates on the Solana platform. OFFICIAL TRUMP has a current supply of 999,998,809.831273 with 281,866,746.118905 in circulation. The last known price of OFFICIAL TRUMP is 1.73532194 USD and is up 9.97 over the last 24 hours. It is currently trading on 744 active market(s) with $259,407,006.57 traded over the last 24 hours. More information can be found at https://gettrumpmemes.com/.

Trump For President

A short-term bounce in the Trump-themed memecoin is drawing FOMO and pump/squeeze calls, but the conversation is predominantly bearish: traders describe it as a speculative pump-and-dump and warn of further losses, while some continue to promote accumulation or another rally.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

AAOI is drawing attention after a sharp, volatile selloff alongside AI and optical-infrastructure peers, with traders pointing to broader concerns about AI spending, valuations and possible further dilution rather than a clear company-specific trigger. Bulls are buying the dip on data-center transceiver demand and upcoming earnings, while bears remain concerned about financing, customer concentration and execution risks.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

Attention centers on claims that POET optical engines were featured in Foxconns photonics ecosystem, which bullish traders view as validation of the existing collaboration and its AI-data-center opportunity; skeptics note that a demo or ecosystem mention is not proof of production orders. Traders are also weighing the reported Marvell-Lumentum deal and upcoming company updates against POETs steep decline and lack of clear commercial execution.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisks shares plunged despite strong results and a raised outlook, as traders focused on Kioxias cautious forecast and fears that NAND pricing growth and the AI-driven memory cycle may be cooling, alongside broader weakness in chip stocks. The community is split between seeing the selloff as an overreaction to solid fundamentals and viewing it as a warning that peak memory pricing and growth could be near.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovins steep selloff ahead of earnings is driving attention, with traders linking the pressure to analyst downgrades, weakness across tech and ad-related stocks, and concerns about advertising demand. Bulls argue the companys growth and cash flow make the shares undervalued, while bears worry that results or guidance could disappoint and extend the decline.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

Attention centers on ABCL635, AbCelleras investigational non-hormonal treatment for menopausal hot flashes, following positive Phase 2 results and discussion of additional safety data and longer-term durability. Traders are optimistic about the drugs potential, while others caution that the early results still need to be confirmed in further studies; recent analyst coverage has added to the interest.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

A sharp gold selloff and break of support dominate discussion, with traders pointing to repriced Fed-rate expectations and possible liquidation pressure as gold falls alongside risk assets. The community is split between calling it a failed safe haven with more downside ahead and viewing the decline as a buying opportunity or temporary washout.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus is drawing attention ahead of its Q3 results, with traders debating whether growth in oncology testing and data licensing can support the stock after its sharp, volatile run. Bulls point to expanded pharma partnerships and short-squeeze potential, while bears cite insider selling, valuation concerns, and a history of post-earnings pullbacks.

Avalanche (AVAX) is a cryptocurrency launched in 2020. Avalanche has a current supply of 470,737,946.01960015 with 444,069,146.01960015 in circulation. The last known price of Avalanche is 8.66516494 USD and is up 1.34 over the last 24 hours. It is currently trading on 1133 active market(s) with $335,296,203.46 traded over the last 24 hours. More information can be found at https://avax.network/.

Avalanche

A sharp AVAX rebound has traders focused on institutional adoption and real-world asset tokenization, especially reports of a Goldman Sachs treasury fund using an Avalanche-based network. Bulls see the activity as validation of the tokenization theme, while skeptics argue the rally may be speculative and point to AVAXs history of giving back gains.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cathie Wood Loads Up On TEM, ILMN And Biotech Stocks — But Pares Stake In This Pharma Giant That Had A Blowout Q3

Equity

Ark Invest increased its exposure to several widely followed biotechnology stocks during the session.

HOOD Stock Heads For Worst Month Since February: Cathie Wood's ARK Loads Up Amid Dip

ARK Investment Management purchased stock worth $9.1 million across three exchange-traded funds on Wednesday. 

Cathie Wood’s ARK Scoops Up 2 Brazilian Stocks Amid Selloff On Lula’s Win; Michael Burry Sees ‘Opportunity’ In One

Following a sharp selloff in Brazilian stocks after election results, ARK Investment Management purchased shares worth $964.8K in Nu Holdings and shares of MercadoLibre worth $3.7 million across two of its exchange-traded funds.

Cathie Wood-Led Ark Invest Sells PLTR, GOOG, SHOP Stocks — But Loads Up On PACB, FRNM And Other Biotech Firms

Ark Invest reduced its exposure to several widely followed technology stocks during the session.

Cathie Wood's ARK Loads Up 38,110 Meta Shares Across 3 ETFs Despite Mounting AI Spending Concerns

ARK's purchases came as Meta stock fell nearly 7% on Thursday, with investors weighing strong advertising growth and early Muse adoption against rising AI infrastructure costs.

Netflix's Higher Spending Fails To Lift Engagement, Says Wolfe In Downgrade — But Argus Still Sees 46% Upside Potential

Cathie Wood's ARK Invest purchased 18,783 Netflix shares through its ARK Next Generation Internet ETF on Wednesday, according to trading disclosures.

SPOT Stock Hits 10-Month High Despite Q3 Earnings Miss: Co-CEO Says Spotify ‘Is Now An Agent,’ Brushes Off AI Churn Fears

Spotify added 6 million premium subscribers in the third quarter, bringing the total to 306 million and beating its guidance.


Are Concerns Over CoreWeave's Debt Overblown? ETFs in Focus

Concerns over CoreWeave's debt may be overblown, while optimism about its business model persists. Explore ETFs offering exposure to the AI computing firm.

CRWV Stock Dips Overnight: Cathie Wood's ARK Investment Loads Up On Neocloud Despite Recent Market Selloff

Cathie Wood's ARK Investment purchased 132,498 shares of CoreWeave across two ETFs on Monday despite a recent selloff in the company. 

Circle CEO Seeks ‘The Happy Middle’ For USDC As BIS Finds Deposit Rates Weigh More On USDC Than Tether 

Cryptocurrency

Higher Fed rates also push banks to provide better deposit rates, which may slow adoption of stablecoins as users weigh their options.


ARK ETF Trust - ARK Next Generation Technology ETF

Bullish Sentiment

<ul class="summary-bullets"><li>ARK's actively managed ETFs made a mix of moves, trimming some established holdings while adding to smaller healthcare names.</li><li>ARK Genomic Revolution ETF increased its exposure to Tempus AI, Pacific Biosciences of California, Beam Therapeutics, and Arcturus Therapeutics.</li><li>Eli Lilly was among ARK’s notable trims on Friday, with its flagship ARK Innovation ETF paring its position despite Lilly’s blowout third-quarter performance.</li></ul>Cathie Wood’s ARK Invest made a series of moves across its actively managed ETFs on Friday, with the firm adding to several healthcare, genomics and cryptocurrency stocks.ARK's actively managed ETFs made a mix of moves, trimming some established holdings while adding to smaller healthcare names. Several stocks appeared in more than one fund.<h2 class="st-heading-2">ARK Loads Up On Biotech Stocks</h2>Tempus AI Inc. (TEM) was one of ARK’s more prominent biotech-related purchases. ARK added 61,114 shares through ARK Genomic Revolution ETF (ARKG) and another 93,407 shares through ARK Innovation ETF (ARKK), increasing its exposure to the AI-powered healthcare and genomics company across two funds.Illumina Inc. (ILMN) was another significant addition, with ARKK buying 43,130 shares of the genomics sequencing company.ARKG also added to several other biotechnology names, buying 133,767 shares of Pacific Biosciences of California Inc. (PACB), 22,687 shares of Beam Therapeutics Inc. (BEAM) and 64,483 shares of Arcturus Therapeutics Holdings Inc. (ARCT). ARKK separately bought another 346,507 shares of Pacific Biosciences.Outside healthcare and genomics, ARK added to Circle Internet Group Inc. (CRCL) and Coinbase Global Inc. (COIN) across multiple ETFs. ARK Blockchain &amp; Fintech Innovation ETF (ARKF) also bought 13,757 shares of Robinhood Markets Inc. (HOOD).<h2 class="st-heading-2">ARK’s Surprise Sell</h2>Eli Lilly &amp; Co. (LLY) was among the notable positions ARK pared on Friday. ARK’s flagship ARKK ETF sold 17,626 shares of the pharmaceutical giant.The move came after Lilly reported third-quarter results that topped expectations, with the company continuing to benefit from strong demand for its diabetes and obesity medicines.ARK also reduced its exposure to CareDx Inc. (CDNA), with the ARKG ETF selling 50,859 shares.Bullish (BLSH) was another recurring sell. ARK sold shares of the crypto-focused financial services company through ARKF, ARKK and ARKW, with the trades totaling more than 238,000 shares across the three ETFs.<a href="https://stocktwits.com/symbol/ARKG">ARKG’s price</a> fell nearly 7% in Friday’s regular trading session. Retail sentiment on Stocktwits around ARKG trended in the ‘bullish’ territory at the time of writing.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/l3-harris-ba-report-record-backlogs-hii-raises-shipbuilding-revenue/cZUKNB8R9cf">Stocktwits Defense Watch: L3Harris, BA Report Record Backlogs, HII Raises FY2026 Shipbuilding Revenue Forecast</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Cathie Wood, Founder & CEO, Ark Invest, speaks during the second day of the FII PRIORITY Summit held at the Faena Hotel on February 20, 2025 in Miami Beach, Florida. (Photo by Joe Raedle/Getty Images)

Arcturus Therapeutics Holdings Inc

ARK Fintech Innovation ETF

ARK Investment Management LLC - ARK Genomic Revolution ETF

ARK Innovation ETF

ARK Next Generation Internet ETF

Beam Therapeutics Inc

Caredx Inc

Coinbase Global Inc

Circle

Robinhood Markets Inc

Illumina Inc

Lilly(Eli) & Co

Pacific Biosciences of California Inc

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

ARKW ARK Next Generation Internet ETF

Fundamentals

Latest ARKW News